title: Liver delipidating effect of a combination of resveratrol and quercetin in rats fed an obesogenic diet.
abstract: Liver steatosis is characterized by an abnormal accumulation of triacylglycerols in this organ. This metabolic disorder is closely associated with obesity. In the present study, we aimed to analyse the effect of a combination of resveratrol and quercetin on liver steatosis in an animal model of dietetic obesity, and to compare it with one induced by the administration of each polyphenol separately. Rats were divided into four dietary groups of nine animals each and fed a high-fat, high-sucrose diet: an untreated control group and three groups treated either with resveratrol (RSV; 15 mg/kg/day), with quercetin (Q; 30 mg/kg/day), or with both (RSV + Q; 15 mg resveratrol/kg/day and 30 mg quercetin/kg/day) for 6 weeks. Liver weight and triacylglycerol content decreased only in the RSV + Q group. A significant reduction in acetyl-CoA carboxylase activity was observed in RSV and RSV + Q groups, without changes in fatty acid synthase activity. A significant increase in carnitine palmitoyltransferase-1a activity was observed only in rats treated with the combination of resveratrol and quercetin, suggesting increased fatty acid oxidation. Citrate synthase, a marker of mitochondrial density, remained unchanged in all groups. No significant changes were observed in the expression of peroxisome proliferator-activated receptor α (PPARα), nuclear respiratory factor 1 (NRF-1) and transcription factor A mitochondrial (TFAM). In conclusion, resveratrol and quercetin together, combining two doses which were shown to be ineffective singly, is an interesting tool to prevent liver steatosis associated with high-fat high-sucrose feeding. The delipidating effect seems to be mediated by increased fatty acid oxidation not associated with increased mitochondriogenesis, and by reduced de novo lipogenesis.
authors.affiliation: Nutrition and Obesity Group, Department of Nutrition and Food Science, Faculty of Pharmacy and Lucio Lascaray Research Center, University of the Basque Country (UPV/EHU), Vitoria, Spain.
authors.forename: Noemí
authors.initials: N
authors.lastname: Arias
authors.forename: M Teresa
authors.initials: MT
authors.lastname: Macarulla
authors.forename: Leixuri
authors.initials: L
authors.lastname: Aguirre
authors.forename: Jonatan
authors.initials: J
authors.lastname: Miranda
authors.forename: María P
authors.initials: MP
authors.lastname: Portillo
mesh_terms: D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D059305:Diet, High-Fat / Q000009:adverse effects; D004353:Drug Evaluation, Preclinical; D002149:Energy Intake; D015870:Gene Expression; D050356:Lipid Metabolism / Q000187:drug effects*; D008099:Liver / Q000378:metabolism* / Q000473:pathology; D008297:Male; D065626:Non-alcoholic Fatty Liver Disease / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism*; D009765:Obesity / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism; D011794:Quercetin / Q000494:pharmacology* / Q000627:therapeutic use; D017208:Rats, Wistar; D000077185:Resveratrol; D013267:Stilbenes / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D013267:Stilbenes; D011794:Quercetin; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000077185:Resveratrol
references.citation: Nutrition. 2013 Mar;29(3):562-7
references.pmid: 23274094
references.citation: Br J Nutr. 2001 May;85(5):607-14
references.pmid: 11348576
references.citation: Clin Exp Gastroenterol. 2014 Jul 05;7:221-39
references.pmid: 25045276
references.citation: Methods. 2001 Dec;25(4):402-8
references.pmid: 11846609
references.citation: Br J Nutr. 2012 Jan;107(2):202-10
references.pmid: 21733326
references.citation: Anal Biochem. 1972 Dec;50(2):509-18
references.pmid: 4630394
references.citation: J Hepatol. 2014 May;60(5):1017-25
references.pmid: 24362075
references.citation: J Am Coll Nutr. 2009 Feb;28(1):43-9
references.pmid: 19571159
references.citation: Cardiovasc Drug Rev. 2004 Fall;22(3):169-88
references.pmid: 15492766
references.citation: J Physiol Biochem. 2014 Jun;70(2):639-46
references.pmid: 24488488
references.citation: Biol Chem. 2007 May;388(5):547-54
references.pmid: 17516851
references.citation: Cell Cycle. 2007 Oct 15;6(20):2495-510
references.pmid: 17726376
references.citation: Gastroenterology. 2005 Jul;129(1):113-21
references.pmid: 16012941
references.citation: PLoS One. 2015 Feb 06;10(2):e0117008
references.pmid: 25658428
references.citation: J Nutr. 2012 Jun;142(6):1026-32
references.pmid: 22535755
references.citation: Acta Pharmacol Sin. 2008 Jun;29(6):698-706
references.pmid: 18501116
references.citation: Nutr Res. 2012 Sep;32(9):701-8
references.pmid: 23084643
references.citation: J Physiol Biochem. 2009 Dec;65(4):369-76
references.pmid: 20358350
references.citation: World J Gastroenterol. 2014 Jun 21;20(23):7366-80
references.pmid: 24966607
references.citation: BMC Gastroenterol. 2008 Sep 09;8:40
references.pmid: 18782455
references.citation: Genes Nutr. 2014 Jan;9(1):361
references.pmid: 24338341
references.citation: J Biol Chem. 1957 May;226(1):497-509
references.pmid: 13428781
references.citation: Anal Biochem. 1976 May 7;72:248-54
references.pmid: 942051
references.citation: Br J Nutr. 2004 Sep;92(3):383-9
references.pmid: 15469641
references.citation: Nutr Cancer. 2008;60(4):442-9
references.pmid: 18584477